MedTrace Feature Article in Børsen

MedTrace Feature Article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt was interviewed about the latest progress, the next steps and his view on market launch estimates as well as exit opportunities. The article requires a subscription to Børsen to access […]

MedTrace Accomplishes Funding of DKK 21M

MedTrace Accomplishes Funding of DKK 21M <!– [if gte mso 9]> <![endif]–> <!– [if gte mso 9]> Normal 0 21 false false false EN-US X-NONE X-NONE <![endif]–><!– [if gte mso 9]> <![endif]–> MedTrace Pharma A/S has completed a capital raise against equity to advance our preparations for the upcoming clinical trial phase III. Three new […]

Putting the Low Radiation Dose of 15O-Water in Perspective

Putting the low radiation of 15O-water in perspective Tracers are radioactive compounds that doctors inject into patients to diagnose various diseases by, for example, following the flow of blood or use of sugar in organs. All tracers come with a radiation dose, but the dose of 15O-water is much lower than all other tracers used […]

ASNC Young Investigator’s Award

Hans Receives the Young Investigator’s Award at ASNC Hans Harms, our VP of Software Development, received the Young Investigator’s Award at the ASNC meeting this year. p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 7.0px Times} The distinguished prize was awarded for his presentation of the study “Elevated Right-Ventricular Blood Flow is Associated with Diastolic Dysfunction […]

Japanese Country Manager

Japanese Country Manager on Board Since the beginning of our activities in Japan, we have had the pleasure of working together with Yumi Murakami from the Danish Embassy in Tokyo. She has since left the embassy and we have been able to engage her part-time to function as Country Manager for our Japanese activities. Her […]

SNMMI Conference

MedTrace Pharma Exhibits at SNMMI The annual meeting of the Society of Nuclear Medicine and Molecular Imaging (#SNMMI) takes place in Anaheim, California this year on June 22-25. Each year the event attracts more than 5,000 participants from all over the world representing hospitals, academia and industry. MedTrace participates this year with a small booth […]

Visit from Japan

Visit from Japan In the beginning of June, a small delegation from Japan visited MedTrace to get a demo of the P3 installation in Aarhus. The chief chemist of Osaka University Hospital, Dr. Sadahiro Naka was accompanied by Dr. Katayama from the nuclear medicine department. In addition, Sumitomo Heavy Industries (SHI) had sent one of […]

NOME Graduation

NOME Team Mentoring Program Graduation Three years ago, MedTrace was accepted into the #NOME life-science mentoring program with an amazing team of legendary mentors. Yesterday, we held our graduation session which, timing-wise, coincided with the installation of our first fully functional prototype in Aarhus University Hospital. In the picture from left to right; CEO Martin […]

RESI 3rd Prize

MedTrace Wins 3rd Prize at the RESI Innovation Challenge in San Francisco We are excited to announce that MedTrace Pharma took home the 3rd prize in the RESI Innovation Challenge arranged by Life Science Nation with 34 finalists during the JP Morgan conference in San Francisco. More than 150 companies had applied for the Innovation […]

New Name and Address

Change of Name and Address Today, MedTrace’s Board of Directors has decided to rename the legal name of the company to MedTrace Pharma to better reflect the company’s activities in the radiopharmaceutical field. The company operates in the grey-zone between medical devices and pharmaceuticals but the end-product we will offer is a radiopharmaceutical in the […]